Fundz

Viome acquires Sōlaria Biō for health innovation

PRIVATEOct 01, 2026

Acquiring Company

Viome

Acquired Company

Sōlaria Biō

BellevueUnited StatesOtherBiotechnologyHealth CareScience And EngineeringGeneticsBiotechnologyHealth CareNutrition

Description

Viome has successfully acquired Sōlaria Biō to expand its portfolio in clinically validated consumer synbiotics and medical foods. This acquisition is set to enhance Viome's mission of improving health outcomes through innovative nutrition solutions. The integration of Sōlaria Biō's offerings will allow Viome to provide more comprehensive health management products. The move signifies Viome's commitment to advancing personalized wellness.

Company Information

Company

Viome

Location

Bellevue, Washington, United States

About

Viome is a pioneering longevity and preventive healthcare company committed to bridging the gap between scientific breakthroughs and their practical implementation as health solutions. Utilizing cutting-edge AI and the world's largest gene expression database, Viome's home-based tests offer individuals personalized nutritional guidance and innovative microbiome health products to enhance lifespan and health. Viome has empowered over half a million users with its unique approach that marries groundbreaking proprietary RNA sequencing methods with AI technology. This combination analyzes epigenetic biomarkers, providing robust, AI-driven health insights that contribute significantly to promoting a healthy lifespan. With its top-tier precision nutrition recommendations, Viome offers a comprehensive and personalized solution to aging - at its optimum. This is more than just health optimization; it's a revolution in understanding how we age and enabling us to do so with vitality and wellness.

Fundz sees it the moment Viome makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jim
Senior decision-maker at this company
••••••••@••••••••

See Jim's verified email →

Lashaun
Likely contact at this company
••••••••@••••••••

See Lashaun's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Viome's next move

Learn about Strategic plan

Frequently asked

Who acquired Sōlaria Biō?

Sōlaria Biō was acquired by Viome, based in Bellevue. The deal was reported on October 1, 2026. Viome is a pioneering longevity and preventive healthcare company committed to bridging the gap between scientific breakthroughs and their practical implementation as health solutions. Viome is privately held and operates in Other.

When did Viome acquire Sōlaria Biō?

Viome's acquisition of Sōlaria Biō was reported on October 1, 2026. Viome has successfully acquired Sōlaria Biō to expand its portfolio in clinically validated consumer synbiotics and medical foods. This acquisition is set to enhance Viome's mission of improving health outcomes through innovative nutrition solutions. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Sōlaria Biō do?

Sōlaria Biō is a company specializing in the development of clinically validated consumer synbiotics and medical foods. It aims to innovate in the field of nutrition by harnessing the power of synbiotics to improve gut health and overall well-being. It is privately held, operating in Biotechnology, and is based in United States.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.